Ellen ‘t Hoen

2.7k total citations
39 papers, 1.1k citations indexed

About

Ellen ‘t Hoen is a scholar working on Economics and Econometrics, Management of Technology and Innovation and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Ellen ‘t Hoen has authored 39 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Economics and Econometrics, 14 papers in Management of Technology and Innovation and 12 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Ellen ‘t Hoen's work include Pharmaceutical Economics and Policy (26 papers), Intellectual Property and Patents (14 papers) and Health Systems, Economic Evaluations, Quality of Life (8 papers). Ellen ‘t Hoen is often cited by papers focused on Pharmaceutical Economics and Policy (26 papers), Intellectual Property and Patents (14 papers) and Health Systems, Economic Evaluations, Quality of Life (8 papers). Ellen ‘t Hoen collaborates with scholars based in Netherlands, United States and Switzerland. Ellen ‘t Hoen's co-authors include Suerie Moon, Nathan Ford, Andy Gray, Brenda Waning, Richard Laing, Jonathan Berger, Alexandra Calmy, Hans V. Hogerzeil, Hiiti Sillo and Rafael Bermúdez and has published in prestigious journals such as The Lancet, Nature Medicine and Clinical Infectious Diseases.

In The Last Decade

Ellen ‘t Hoen

39 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ellen ‘t Hoen Netherlands 17 559 254 210 188 149 39 1.1k
Sabine Vogler Austria 26 1.7k 3.1× 108 0.4× 135 0.6× 102 0.5× 311 2.1× 126 2.2k
Sripen Tantivess Thailand 22 617 1.1× 106 0.4× 160 0.8× 45 0.2× 250 1.7× 50 1.3k
Richard Muga Kenya 15 174 0.3× 611 2.4× 136 0.6× 43 0.2× 538 3.6× 30 1.7k
David Wilson United States 15 141 0.3× 192 0.8× 372 1.8× 58 0.3× 109 0.7× 43 984
T. Joseph Mattingly United States 15 206 0.4× 135 0.5× 59 0.3× 30 0.2× 46 0.3× 97 856
Pankaj Bahuguna India 23 375 0.7× 95 0.4× 218 1.0× 17 0.1× 485 3.3× 81 1.4k
Gabriela Costa Chaves Brazil 13 275 0.5× 119 0.5× 86 0.4× 101 0.5× 52 0.3× 33 606
Brenda Waning United States 8 321 0.6× 84 0.3× 53 0.3× 69 0.4× 132 0.9× 13 527
Andrew Mulcahy United States 20 564 1.0× 218 0.9× 103 0.5× 51 0.3× 103 0.7× 82 1.2k
Eric Osei Ghana 12 121 0.2× 63 0.2× 201 1.0× 15 0.1× 95 0.6× 31 682

Countries citing papers authored by Ellen ‘t Hoen

Since Specialization
Citations

This map shows the geographic impact of Ellen ‘t Hoen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ellen ‘t Hoen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ellen ‘t Hoen more than expected).

Fields of papers citing papers by Ellen ‘t Hoen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ellen ‘t Hoen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ellen ‘t Hoen. The network helps show where Ellen ‘t Hoen may publish in the future.

Co-authorship network of co-authors of Ellen ‘t Hoen

This figure shows the co-authorship network connecting the top 25 collaborators of Ellen ‘t Hoen. A scholar is included among the top collaborators of Ellen ‘t Hoen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ellen ‘t Hoen. Ellen ‘t Hoen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Howell, Jessica, Alisa Pedrana, Sophia Schroeder, et al.. (2020). A global investment framework for the elimination of hepatitis B. Journal of Hepatology. 74(3). 535–549. 63 indexed citations
2.
Hoen, Ellen ‘t. (2020). Protect against market exclusivity in the fight against COVID-19. Nature Medicine. 26(6). 813–813. 9 indexed citations
3.
Pedrana, Alisa, Jessica Howell, Nick Scott, et al.. (2020). Global hepatitis C elimination: an investment framework. ˜The œLancet. Gastroenterology & hepatology. 5(10). 927–939. 31 indexed citations
4.
Hoen, Ellen ‘t, et al.. (2019). Improving affordability of new Essential Cancer Medicines. The Lancet Oncology. 20(8). 1052–1054. 7 indexed citations
5.
Douglass, Caitlin, Alisa Pedrana, Jeffrey V. Lazarus, et al.. (2018). Pathways to ensure universal and affordable access to hepatitis C treatment. BMC Medicine. 16(1). 175–175. 53 indexed citations
6.
Hoen, Ellen ‘t, et al.. (2018). Patent challenges in the procurement and supply of generic new essential medicines and lessons from HIV in the southern African development community (SADC) region.. Journal of Pharmaceutical Policy and Practice. 11(1). 31–31. 3 indexed citations
7.
Hoen, Ellen ‘t, Pascale Boulet, & Brook K. Baker. (2017). Data exclusivity exceptions and compulsory licensing to promote generic medicines in the European Union: A proposal for greater coherence in European pharmaceutical legislation. Journal of Pharmaceutical Policy and Practice. 10(1). 19–19. 17 indexed citations
8.
Hoen, Ellen ‘t. (2016). Indian hepatitis C drug patent decision shakes public health community. The Lancet. 387(10035). 2272–2273. 8 indexed citations
9.
Gray, Andy, Veronika J. Wirtz, Ellen ‘t Hoen, Michael R. Reich, & Hans V. Hogerzeil. (2015). Essential medicines are still essential. The Lancet. 386(10004). 1601–1603. 23 indexed citations
10.
Hoen, Ellen ‘t & F. Brian Pascual. (2015). Viewpoint: Counterfeit medicines and substandard medicines: Different problems requiring different solutions. Journal of Public Health Policy. 36(4). 384–389. 7 indexed citations
11.
Hoen, Ellen ‘t, Hans V. Hogerzeil, Jonathan D. Quick, & Hiiti Sillo. (2014). A quiet revolution in global public health: The World Health Organization’s Prequalification of Medicines Programme. Journal of Public Health Policy. 35(2). 137–161. 56 indexed citations
12.
Ford, Nathan, Zara Shubber, Peter Saranchuk, et al.. (2013). Burden of HIV-Related Cytomegalovirus Retinitis in Resource-Limited Settings: A Systematic Review. Clinical Infectious Diseases. 57(9). 1351–1361. 64 indexed citations
13.
Moon, Suerie, Rafael Bermúdez, & Ellen ‘t Hoen. (2012). Innovation and Access to Medicines for Neglected Populations: Could a Treaty Address a Broken Pharmaceutical R&D System?. PLoS Medicine. 9(5). e1001218–e1001218. 52 indexed citations
14.
Hoen, Ellen ‘t, et al.. (2012). The role of intellectual property rights in treatment access. Current Opinion in HIV and AIDS. 8(1). 70–74. 4 indexed citations
15.
Hoen, Ellen ‘t, Jonathan Berger, Alexandra Calmy, & Suerie Moon. (2011). Driving a decade of change: HIV/AIDS, patents and access to medicines for all. Journal of the International AIDS Society. 14(1). 15–15. 144 indexed citations
16.
Bermudez, Jorge Antônio Zepeda & Ellen ‘t Hoen. (2010). The UNITAID Patent Pool Initiative: Bringing Patents Together for the Common Good. The Open AIDS Journal. 4(1). 37–40. 32 indexed citations
17.
Dukes, M. N. G. & Ellen ‘t Hoen. (2007). Compensation for drug injury: A novel solution for diethylstilbestrol?. International Journal of Risk & Safety in Medicine. 19(1-2). 87–91. 1 indexed citations
18.
Hoen, Ellen ‘t, et al.. (2007). Compensation for diethylstilbestrol injury. The Lancet. 369(9557). 173–174. 1 indexed citations
19.
Hoen, Ellen ‘t. (2006). Report of the Commission on Intellectual Property Rights, Innovation and Public Health: a call to governments. Bulletin of the World Health Organization. 84(5). 421–423. 13 indexed citations
20.
Ford, Nathan & Ellen ‘t Hoen. (2001). The Global Health Fund: moral imperative or industry subsidy?. The Lancet. 358(9281). 578–578. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sabine Vogler Breakdown of academic impact, for papers by Sripen Tantivess Breakdown of academic impact, for papers by Richard Muga Breakdown of academic impact, for papers by David Wilson Breakdown of academic impact, for papers by T. Joseph Mattingly Breakdown of academic impact, for papers by Pankaj Bahuguna Breakdown of academic impact, for papers by Gabriela Costa Chaves Breakdown of academic impact, for papers by Brenda Waning Breakdown of academic impact, for papers by Andrew Mulcahy Breakdown of academic impact, for papers by Eric Osei
Rankless by CCL
2026